UroGen: June 13 PDUFA For Potential Bladder Cancer Blockbuster Sets Up Strong Buy

UroGen: June 13 PDUFA For Potential Bladder Cancer Blockbuster Sets Up Strong Buy #UroGen #June #PDUFA…

Protara to present bladder cancer trial data at AUA meeting

Protara to present bladder cancer trial data at AUA meeting#Protara #present #bladder #cancer #trial #data #AUA…

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III…

Bayer hit with $2 billion Roundup verdict in US state of Georgia cancer case

Bayer hit with $2 billion Roundup verdict in US state of Georgia cancer case#Bayer #hit #billion…

Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer#Akeso039s #Penpulimab #Receives #NMPA #Approval #FirstLine…

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on…

Astellas Pharma: Raising New, As Yet Unanswered Questions In Stomach Cancer And Moving Their Pipeline Forward

Astellas Pharma: Raising New, As Yet Unanswered Questions In Stomach Cancer And Moving Their Pipeline Forward…

ELAHERE ® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

ELAHERE ® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients#ELAHERE…

Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment

Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer…

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that.

Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer…

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer#Data…

WHO calls for tobacco-style cancer warning labels on alcoholic drinks across Europe

WHO calls for tobacco-style cancer warning labels on alcoholic drinks across Europe#calls #tobaccostyle #cancer #warning #labels…

Could this startup’s compact nuclear reactors revolutionize cancer detection?

As cancer rates in the West, and globally, tack upwards due to lifestyle and environmental pollution,…

US government could seek over $1 billion from J&J for cancer treatment costs

US government could seek over $1 billion from J&J for cancer treatment costs#government #seek #billion #JampJ…

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY ® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY ® as Part of Adjuvant Regimen for Patients with…

New breast cancer treatment has this tiny cap soaring

Good day, 360! Here are some of our top movers today. And if you love LOTTOS…

Sisk wins £300m Great Ormond Street cancer care contract

The new children’s cancer centre will also include a new main entrance to the hospital The…

Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor…

Pfizer’s BRAFTOVI ® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial show objective response rate…

Merck and Eisai report mixed results in Phase 3 cancer trial By Investing.com

RAHWAY, N.J. & NUTLEY, N.J. – Merck (NSE:) & Co., Inc. (NYSE:) and Eisai Co., Ltd.…

MidAmerica Cancer Care Joins American Oncology Network By Investing.com

KANSAS CITY, Mo., Jan. 22, 2025 (GLOBE NEWSWIRE) — MidAmerica Cancer Care  (MACC), a trusted name…

ImmunityBio: Making Its Next Strikes After Bladder Cancer Approval (Upgrade) (NASDAQ:IBRX)

This article was written by Follow I have my PhD in biochemistry and have worked for…